P

Inventor

PETROS ANDREW M

US13 patents
⚠️ This page may combine multiple inventors who share the name “PETROS ANDREW M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT LAB

4 patents
US7504512B2Mar 17, 2009

N-acylsulfonamide apoptosis promoters

ABBOTT LAB58 citations97
US6720338B2Apr 13, 2004

N-acylsulfonamide apoptosis promoters

ABBOTT LAB98 citations97
US7754886B2Jul 13, 2010

N-acylsulfonamide apoptosis promoters

ABBOTT LAB34 citations90
US7226992B1Jun 5, 2007

Mutant Bcl-2 proteins and uses thereof

ABBOTT LAB0 citations50

BRUNCKO MILAN

3 patents
US8586754B2Nov 19, 2013

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

BRUNCKO MILAN72 citations97
US8084607B2Dec 27, 2011

Apoptosis promoters

BRUNCKO MILAN43 citations93

BAELL JONATHAN BAYLDON

3 patents
US8114893B2Feb 14, 2012

Compounds and methods of use

BAELL JONATHAN BAYLDON43 citations95
US8232273B2Jul 31, 2012

Heterocyclic compounds and methods of use

BAELL JONATHAN BAYLDON28 citations91
US8518970B2Aug 27, 2013

Compounds and methods of use

BAELL JONATHAN BAYLDON29 citations90

ABBVIE INC

2 patents
US9125913B2Sep 8, 2015

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

ABBVIE INC10 citations84
US9072748B2Jul 7, 2015

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

ABBVIE INC11 citations84

GENENTECH INC

1 patent
US9067928B2Jun 30, 2015

Compounds and methods of use

GENENTECH INC5 citations82